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ABSTRACT
Objectives: In this study we aimed to investigate whether P-selectin gene polymorphism is associated with thrombosis in Sudanese pregnant women 
in Khartoum state.
Methods: After informed consent, 96 Sudanese pregnant women with thrombosis and 53 healthy pregnant women were recruited in the study. 
Genomic DNA was isolated from whole blood. Genotyping of PSGL-1 gene was performed by polymerase chain reaction amplification for exon 14 and 
electrophoresis.
Results: The frequency of the B allele was found to be significantly higher in pregnant women with thrombosis (26%) compared to the controls 
(17.4%).
Conclusion: The AB genotype was found to be higher in women with thrombosis 40.6% than in healthy controls 20% (p=0.02). Our results suggest 
that the PSGL-1 AB genotype is associated with an increased risk of thrombosis in Sudanese pregnant women.
Keywords: P-selectin glycoprotein ligand-1 polymorphisms, Variable number of tandem repeats, Thrombosis, Deep vein thrombosis.
INTRODUCTION
It is well known that normal pregnancy is associated with a 
hypercoagulable state, resulting in a moderate risk for thrombosis 
during the different trimesters of pregnancy. From the viewpoint 
of coagulation/fibrinolysis changes, the follow-up of thrombophilia 
markers could be recommended when levels of coagulation parameters 
exceed the normal values during pregnancy [1]. Tissue factor interacts 
with activated factor VII to initiate a series of coordinated enzymatic 
reactions leading to the formation of thrombin. Thrombin then converts 
fibrinogen to fibrin to stabilize the initial platelet plug and to form a 
fibrin clot [2]. Activation of platelets leads to the exposure of P-selectin 
on the surface of platelets. P-selectin is an adhesion molecule which 
mediates the interaction of activated endothelial cells or platelets with 
leukocytes.
P-selectin concentration had been reported in the blood of patients 
with thrombotic consumptive platelet disorders, such as disseminated 
intravascular coagulation [3]. Activated platelets may be sequestered 
during thrombus formation, and thus, platelet P-selectin may 
underestimate the actual platelet activation. Activated platelets may 
also be attached to leukocytes. It was found that platelet-monocyte 
complexes are better markers for thrombotic tendency than platelet 
P-selectin that was formerly regarded as the gold standard [4]. Soluble 
P-selectin may be elevated disproportionately to platelet P-selectin 
because of the presence of selectin polymorphism that can influence 
P-selectin shedding [5]. Now the risk of venous thromboembolism 
(VTE) is increased during normal pregnancy is well known. In Sweden 
and Norway during the early 1990s, VTE occurred in slightly more 
than one of 1000 pregnant women [6,7]. There is a continued interest 
in developing therapeutics to combat human injury sustained from a 
myocardial infarction. To date, the therapy for acute ischemia of the 
heart has been largely directed toward reestablishing perfusion of the 
ischemic myocardium or toward the coagulation system to prevent 
thrombosis. Therefore, strategies that would improve treatment of 
different forms of myocardial ischemia are reasonable [8].
P-selectin expressed on activated platelets binds to P-selectin 
glycoprotein ligand-1 (PSGL-1) on neutrophils, recruits leukocytes 
into growing thrombi, and promotes fibrin deposition [9]. A significant 
increase in plasma P-selectin concentration had been reported in 
blood of patients with thrombotic consumptive platelet disorders, 
such as thrombotic thrombocytopenia purpura (TTP), or heparin-
induced thrombocytopenia (HIT). In thrombotic processes, during 
the association of leukocytes with platelets and endothelial cells [10]. 
Elevated soluble P-selectin levels are predictors of early adverse events 
in patients with chest pain presumed caused by myocardial ischemia 
[11]. Thus, the correct identification of the risk factors associated with 
the stroke patients prior helps to bring down the cost burden along 
with improvement in the quality of life effectively [12].
There is a relatively common genetic variation in PSGL-1 with a 
variable number of tandem repeats (VNTR) affecting the length of the 
extracellular domain of PSGL-1 molecule through the distance from the 
P-selectin binding site to the cell surface [13]. Three allelic variants were 
identified in the human population. The 3 alleles, A, B, and C, from largest 
to smallest, contained 16, 15, and 14 decameric repeats, respectively, 
with the B variant lacking repeat 2 and the C variant retaining repeat 
2 but lacking repeats 9 and 10. Allele frequencies were highest for the 
A variant and lowest for the C variant; the frequencies were described 
as 0.81, 0.17, and 0.02 in the Local population. Homozygous carriers 
for the shorter B and C short alleles had a lower risk for premature 
myocardial infarction due to lower adhesive capacity [14]. Further 
studies may clarify whether other haplotypes of P-selectin and/or 
PSGL-1 gene substantially influence the risk and outcomes of adverse 
vascular events with or without medication [15]. P-selectin is highly 
polymorphic having several genetic variants; the Thr715Pro variant 
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located in the last consensus repeat region of P-selectin is probably 
the most intensively studied [16,17]. The substitution of threonine 
for proline induces a conformational change in the precursor protein, 
which may influence its intracellular transportation and secretion 
leading to reduced expression and/or shedding of P-selectin, and thus, 
fewer cellular interactions are developed. The Pro715 allele alters 




This study included 96 (64%) pregnant women patients with thrombosis 
with mean age of 32.56±3.67 as the test group and 53 (36%) healthy 
pregnant women as the control group with mean age of 32, standard 
deviation = 3.66, attended Khartoum Teaching Hospital, Omdurman 
Maternity Hospital, and El Shaikh Faddul Maternity Hospital, Khartoum 
state. They were included during March 2015–June 2017. The diagnosis 
and classification of thrombosis or DVT were based on information 
from known DVT- or VTE-hospitalized patients, and it follows inclusion 
and exclusion criteria that depend on current or previous DVT or VTE 
or history of thrombosis. Informed consent was obtained from all 
participants. The demographic data were obtained using pre-designed 
questionnaire which includes age, number of pregnancies, history of 
thrombosis in previous pregnancies, and residence. 3 ml venous blood 
was collected from patients and controls in EDTA as an anticoagulant.
Laboratory analysis (molecular biology techniques)
Genomic DNA - Isolation from blood leukocytes using salting out method
↓
 Electrophoresis of the extracted DNA in agarose gel
↓
PCR - Amplification of Exons 14 of P-selectin glycoprotein ligand-1 
(PSGL-1)
↓
  Electrophoresis of PCR products
DNA isolation was done using DNA salting out method which is simple, 
rapid, and of minimum cost. DNA was detected by electrophoresis 
on agarose gel stained with ethidium bromide, which has an intense 
fluorescence excited by ultraviolet radiation when complexes with the 
nucleic acid. Then, the quality and quantity of extracted DNA were then 
measured using the spectrophotometer at wave length of 260 nm and 
280 nm.
Polymerase chain reaction (PCR)
Primers were designed using the published data for human PSGL-1 
gene exon 14.
Primers sequences:
F primer5′‐CCT GTC CAC GGA TTC AGC‐3
R primer5′‐GGG AAT GCC CTT GTG AGT AA‐3
PCR condition
The readymade intron premix kits for 20 μl were used. The PCR 
condition used is shown in Table 1.
The PCR products were separated on agarose gels and visualized by 
ethidium bromide staining. Amplicon band size of 558, 528, and 498 bp 
corresponded to alleles A, B, and C, respectively.
Statistical test
Chi-squaredX test was used to compare the values of the distribution of VNTR 
genotypes/haplotypes among case patients and control subjects and used 
to calculate the 95% confidence intervals and p values for crude odds ratios 
(OR). The statistical analysis was performed using IBM SPSS V 22 program.
RESULTS
The study recruited 149 Sudanese pregnant women Mean age 32 
years, Standard deviation = 3.67, the healthy pregnant women were 
53 (36%) and those with thrombosis comprises 96 (64%). The allelic 
frequency of the PSGL-1 gene of A, B, and C alleles was found to be 
85%, 14%, and 1%, respectively (Fig. 1), and in patients (pregnant with 
thrombosis), there was difference in the frequency of B allele compared 
with the controls (pregnant without thrombosis) which is statistically 
significant (26% versus 17.4% p=0.01). The AB genotype was found to 
be significantly more frequent among pregnant with thrombosis than in 
controls (40.6% versus 20% p=0.02) (Table 2 and Fig. 2).
DISCUSSION
P-selectin on the activated platelets and endothelial cells binds to PSGL-
1 ligand on the monocytes or on the leucocyte-derived microparticles 
and stimulates tissue factor expression [19]. The P-selectin/PSGL-1 
interaction is definitive in inflammation and thrombosis. It has been 
shown that blockade of P-selectin or PSGL-1 prevents fibrin formation 
in animal models [20]. Tissue-factor accumulation and fibrin generation 
were both markedly reduced in mice deficient in P-selectin or PSGL-1 [21]. 
These findings show that the interaction of P-selectin with PSGL-1 on 
microparticles is essential for fibrin generation which enhances thrombus 
formation. In relation to this background, this study was designed to focus 
on assessing the frequencies of different PSGL-1 polymorphic forms and 
their relationship with thrombosis in pregnant women. We found that the 
frequency of AB genotype was significantly higher in pregnant women 
with thrombosis compared with pregnant women without thrombosis 
(p=0.02) which indicates that the presence of PSGL-1 AB genotype might 
increase the risk of thrombosis in pregnant women, and the same thing 
with B allele was found at a higher frequency in pregnant women with 
thrombosis than in healthy controls (p=0.01) which supports the role of 
the PSGL-1 VNTR polymorphism as a marker of thrombotic disease.
In Sudan, no previous study bound thrombotic pregnant women with 
PSGL-1 levels or gene polymorphism in patients compared with normal 
pregnant women that we have done in this study although many studies 
suggest that there is a strong relationship between PSGL-1 levels and 
their genetic polymorphisms and thrombosis [18]. A study done by 
Kappelmayer and Nagy suggests that PSGL-1 and other selectin  ligands 
represent diagnostic biomarkers and ideal targets for the intervention of 
thrombosis and cancer [22]. Recently, many studies have demonstrated 
the functional relevance of PSGL-1 polymorphism and different forms 
of cardiovascular diseases [23], and this indicates that the P-selectin/
PSGL polymorphism may be important in initiating thrombosis in 
pregnant women and suggests that detection of P-selectin/PSGL 
polymorphisms in those categories should be made to avoid pregnancy 
complications.
Table 1: PCR conditions for P‑selectin glycoprotein ligand‑1 and 
exon 14
Cycle Temperate Time
Initial denaturation 95°C 3 min
Denaturation 95°C 30 s
Annealing 60°C 30 s
Extension 72°C 30 s
Close cycle. Cycle repeated 30 times
Final extension 72°C 7 min
PCR: Polymerase chain reaction
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CONCLUSION
We concluded that the presence of PSGL-1 AB genotype might increase 
the risk of thrombosis in pregnant women and that the minor B allele 
results in an increased ability for thrombus formation.
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